Cargando…
Safety and efficacy of thromboelastography guidance of antifibrinolytic therapy in trauma patients: An observational cohort analysis
BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic therapy intended to decrease blood loss and improve hemostasis in traumatic hemorrhage. Viscoelastic assays, such as thromboelastography (TEG), allow for the identification of a patient's specific hemostasis. The purpose of this research...
Autores principales: | Heilbronner, Rachel N., Kincaid, Michelle, Walliser, Grant, Pershing, Michelle, Spalding, M. Chance |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318174/ https://www.ncbi.nlm.nih.gov/pubmed/34395207 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_79_20 |
Ejemplares similares
-
The Safety and Efficacy of Antifibrinolytic Therapy in Neonatal Cardiac Surgery
por: Lin, Chih-Yuan, et al.
Publicado: (2015) -
Antifibrinolytics
por: Székely, A, et al.
Publicado: (2014) -
Antifibrinolytics in a rural trauma state: assessing the opportunities
por: Bardes, James M, et al.
Publicado: (2017) -
Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
por: Dybdahl, Daniel, et al.
Publicado: (2019) -
Tranexamic Acid in Civilian Trauma Care in the California Prehospital Antifibrinolytic Therapy Study
por: Neeki, Michael M., et al.
Publicado: (2018)